FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2578833489> ?p ?o ?g. }

• W2578833489 endingPage "5122" @default.
• W2578833489 startingPage "5110" @default.
• W2578833489 abstract "This study investigates the consequences of elevating sphingomyelin synthase 1 (SMS1) activity, which generates the main mammalian sphingolipid, sphingomyelin. HepG2 cells stably transfected with SMS1 (HepG2-SMS1) exhibit elevated enzyme activity in vitro and increased sphingomyelin content (mainly C22:0- and C24:0-sphingomyelin) but lower hexosylceramide (Hex-Cer) levels. HepG2-SMS1 cells have fewer triacylglycerols than controls but similar diacylglycerol acyltransferase activity, triacylglycerol secretion, and mitochondrial function. Treatment with 1 mm palmitate increases de novo ceramide synthesis in both cell lines to a similar degree, causing accumulation of C16:0-ceramide (and some C18:0-, C20:0-, and C22:0-ceramides) as well as C16:0- and C18:0-Hex-Cers. In these experiments, the palmitic acid is delivered as a complex with delipidated BSA (2:1, mol/mol) and does not induce significant lipotoxicity. Based on precursor labeling, the flux through SM synthase also increases, which is exacerbated in HepG2-SMS1 cells. In contrast, palmitate-induced lipid droplet formation is significantly reduced in HepG2-SMS1 cells. [14C]Choline and [3H]palmitate tracking shows that SMS1 overexpression apparently affects the partitioning of palmitate-enriched diacylglycerol between the phosphatidylcholine and triacylglycerol pathways, to the benefit of the former. Furthermore, triacylglycerols from HepG2-SMS1 cells are enriched in polyunsaturated fatty acids, which is indicative of active remodeling. Together, these results delineate novel metabolic interactions between glycerolipids and sphingolipids. This study investigates the consequences of elevating sphingomyelin synthase 1 (SMS1) activity, which generates the main mammalian sphingolipid, sphingomyelin. HepG2 cells stably transfected with SMS1 (HepG2-SMS1) exhibit elevated enzyme activity in vitro and increased sphingomyelin content (mainly C22:0- and C24:0-sphingomyelin) but lower hexosylceramide (Hex-Cer) levels. HepG2-SMS1 cells have fewer triacylglycerols than controls but similar diacylglycerol acyltransferase activity, triacylglycerol secretion, and mitochondrial function. Treatment with 1 mm palmitate increases de novo ceramide synthesis in both cell lines to a similar degree, causing accumulation of C16:0-ceramide (and some C18:0-, C20:0-, and C22:0-ceramides) as well as C16:0- and C18:0-Hex-Cers. In these experiments, the palmitic acid is delivered as a complex with delipidated BSA (2:1, mol/mol) and does not induce significant lipotoxicity. Based on precursor labeling, the flux through SM synthase also increases, which is exacerbated in HepG2-SMS1 cells. In contrast, palmitate-induced lipid droplet formation is significantly reduced in HepG2-SMS1 cells. [14C]Choline and [3H]palmitate tracking shows that SMS1 overexpression apparently affects the partitioning of palmitate-enriched diacylglycerol between the phosphatidylcholine and triacylglycerol pathways, to the benefit of the former. Furthermore, triacylglycerols from HepG2-SMS1 cells are enriched in polyunsaturated fatty acids, which is indicative of active remodeling. Together, these results delineate novel metabolic interactions between glycerolipids and sphingolipids." @default.
• W2578833489 created "2017-01-26" @default.
• W2578833489 creator A5002672605 @default.
• W2578833489 creator A5010342381 @default.
• W2578833489 creator A5020444852 @default.
• W2578833489 creator A5033255398 @default.
• W2578833489 creator A5060804191 @default.
• W2578833489 creator A5066374603 @default.
• W2578833489 creator A5070557696 @default.
• W2578833489 creator A5088805877 @default.
• W2578833489 date "2017-03-01" @default.
• W2578833489 modified "2023-10-17" @default.
• W2578833489 title "Novel Interconnections in Lipid Metabolism Revealed by Overexpression of Sphingomyelin Synthase-1" @default.
• W2578833489 cites W1007591387 @default.
• W2578833489 cites W1368384 @default.
• W2578833489 cites W1495307542 @default.
• W2578833489 cites W1500243384 @default.
• W2578833489 cites W1514634719 @default.
• W2578833489 cites W1518225155 @default.
• W2578833489 cites W1535781736 @default.
• W2578833489 cites W1538201785 @default.
• W2578833489 cites W1549255782 @default.
• W2578833489 cites W1557594417 @default.
• W2578833489 cites W1594700564 @default.
• W2578833489 cites W1859298280 @default.
• W2578833489 cites W1957489287 @default.
• W2578833489 cites W1964392625 @default.
• W2578833489 cites W1968572179 @default.
• W2578833489 cites W1973186908 @default.
• W2578833489 cites W1977563244 @default.
• W2578833489 cites W1983516478 @default.
• W2578833489 cites W1984413737 @default.
• W2578833489 cites W1995590289 @default.
• W2578833489 cites W1998546556 @default.
• W2578833489 cites W2003853320 @default.
• W2578833489 cites W2011185005 @default.
• W2578833489 cites W2011647937 @default.
• W2578833489 cites W2024552332 @default.
• W2578833489 cites W2027632911 @default.
• W2578833489 cites W2028956758 @default.
• W2578833489 cites W2034863466 @default.
• W2578833489 cites W2034883068 @default.
• W2578833489 cites W2047716152 @default.
• W2578833489 cites W2051101227 @default.
• W2578833489 cites W2051423453 @default.
• W2578833489 cites W2063742440 @default.
• W2578833489 cites W2068348872 @default.
• W2578833489 cites W2082671921 @default.
• W2578833489 cites W2091108957 @default.
• W2578833489 cites W2102100103 @default.
• W2578833489 cites W2121129782 @default.
• W2578833489 cites W2122323926 @default.
• W2578833489 cites W2128085766 @default.
• W2578833489 cites W2132611682 @default.
• W2578833489 cites W2133396278 @default.
• W2578833489 cites W2134423247 @default.
• W2578833489 cites W2148189709 @default.
• W2578833489 cites W2150339227 @default.
• W2578833489 cites W2155894864 @default.
• W2578833489 cites W2156802128 @default.
• W2578833489 cites W2159480841 @default.
• W2578833489 cites W2095231777 @default.
• W2578833489 doi "https://doi.org/10.1074/jbc.m116.751602" @default.
• W2578833489 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5377821" @default.
• W2578833489 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28087695" @default.
• W2578833489 hasPublicationYear "2017" @default.
• W2578833489 type Work @default.
• W2578833489 sameAs 2578833489 @default.
• W2578833489 citedByCount "16" @default.
• W2578833489 countsByYear W25788334892017 @default.
• W2578833489 countsByYear W25788334892018 @default.
• W2578833489 countsByYear W25788334892019 @default.
• W2578833489 countsByYear W25788334892020 @default.
• W2578833489 countsByYear W25788334892021 @default.
• W2578833489 countsByYear W25788334892023 @default.
• W2578833489 crossrefType "journal-article" @default.
• W2578833489 hasAuthorship W2578833489A5002672605 @default.
• W2578833489 hasAuthorship W2578833489A5010342381 @default.
• W2578833489 hasAuthorship W2578833489A5020444852 @default.
• W2578833489 hasAuthorship W2578833489A5033255398 @default.
• W2578833489 hasAuthorship W2578833489A5060804191 @default.
• W2578833489 hasAuthorship W2578833489A5066374603 @default.
• W2578833489 hasAuthorship W2578833489A5070557696 @default.
• W2578833489 hasAuthorship W2578833489A5088805877 @default.
• W2578833489 hasBestOaLocation W25788334891 @default.
• W2578833489 hasConcept C134018914 @default.
• W2578833489 hasConcept C170493617 @default.
• W2578833489 hasConcept C181199279 @default.
• W2578833489 hasConcept C185592680 @default.
• W2578833489 hasConcept C190283241 @default.
• W2578833489 hasConcept C195794163 @default.
• W2578833489 hasConcept C2777391703 @default.
• W2578833489 hasConcept C2777851122 @default.
• W2578833489 hasConcept C2778163477 @default.
• W2578833489 hasConcept C2778703144 @default.
• W2578833489 hasConcept C2779306644 @default.
• W2578833489 hasConcept C2910328161 @default.
• W2578833489 hasConcept C36020004 @default.

• next